Pzena Investment Management LLC Sells 14,169 Shares of HCA Healthcare, Inc. $HCA

Pzena Investment Management LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 99,982 shares of the company’s stock after selling 14,169 shares during the quarter. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $38,303,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $1,021,000. Farther Finance Advisors LLC grew its stake in shares of HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after acquiring an additional 242 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after acquiring an additional 737 shares during the last quarter. SG Americas Securities LLC grew its stake in shares of HCA Healthcare by 1,405.0% in the first quarter. SG Americas Securities LLC now owns 7,194 shares of the company’s stock worth $2,486,000 after acquiring an additional 6,716 shares during the last quarter. Finally, Simon Quick Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter worth $345,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $414.73 on Monday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The stock has a market cap of $97.04 billion, a PE ratio of 17.43, a PEG ratio of 1.31 and a beta of 1.40. The business has a fifty day moving average of $405.12 and a two-hundred day moving average of $376.08.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company posted $5.50 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HCA shares. Truist Financial raised their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Wells Fargo & Company raised their target price on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Finally, Robert W. Baird lifted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $422.31.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.